4 Alzheimers Disease Clinical Trials in Fort Smith, AR (2026)

Q: How do I join a clinical trial in Fort Smith?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Smith research site will contact you.

Recruiting Alzheimers Disease Studies in Fort Smith

NCT06073431Recruiting

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

This study evaluates cancer-related weight and muscle mass loss, symptoms, and physical function (cachexia) in patients undergoing treatment for colorectal, lung, or pancreatic cancer that cannot be r...

Fort Smith, AR800 participantsUniversity of Rochester

View Study Details

NCT02734537Recruiting

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

This phase II trial studies how well radiation therapy with or without cisplatin works in treating patients with stage III-IVA squamous cell carcinoma of the head and neck who have undergone surgery. ...

Fort Smith, ARPHASE2189 participantsECOG-ACRIN Cancer Research Group

View Study Details

NCT07244263Recruiting

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) is a skin condition that causes deep, painful bumps on the skin. These bumps usually appear in an area where the skin rubs together. They start as small bumps but may bec...

Fort Smith, ARPHASE290 participantsTakeda

View Study Details

NCT03739814Recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly ...

Fort Smith, ARPHASE284 participantsNational Cancer Institute (NCI)

View Study Details

About Alzheimers Disease Clinical Trials in Fort Smith

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 4 alzheimers disease clinical trials recruiting participants in Fort Smith, AR. These studies are seeking a combined 1,163 participants. Research is being sponsored by University of Rochester, ECOG-ACRIN Cancer Research Group, Takeda and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in Fort Smith — FAQ

Are there alzheimers disease clinical trials in Fort Smith?

Yes, there are 4 alzheimers disease clinical trials currently recruiting in Fort Smith, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fort Smith?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Smith research site will contact you about next steps.

Are clinical trials in Fort Smith free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fort Smith studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 4 active trials in Fort Smith are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated July 22, 2026 from ClinicalTrials.gov